Valley National Advisers Inc Arrowhead Pharmaceuticals, Inc. Transaction History
Valley National Advisers Inc
- $557 Million
- Q4 2024
A detailed history of Valley National Advisers Inc transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 200 shares of ARWR stock, worth $2,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$2,764
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ARWR
# of Institutions
302Shares Held
95.7MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$168 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$154 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$83.1 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$72.3 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.46B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...